FI
BIIB icon

Fosun International’s Biogen BIIB Stock Holding History

Fosun International’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,400
Closed -$559K – 306
2019
Q1 		$559K Buy
2,400
+400
+20% +$126K 0.04% 213
2018
Q4 		$589K Hold
2,000
– – 0.04% 199
2018
Q3 		$711K Buy
+2,000
New +$689K 0.03% 164

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fosun International's BIIB Position: Q2 2019 in Review

Fosun International sold out of Biogen (BIIB) in Q2 2019, closing a stake of 2,400 shares — an estimated $559K sold.

Fosun International first reported a position in BIIB in Q3 2018 and held it in 3 quarters. The position peaked at $711K in Q3 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Fosun International reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Fosun International sold 2,400 Biogen shares in Q2 2019, an estimated $559K.
  • Fosun International first reported a position in Biogen in Q3 2018 and held it in 3 quarters.
  • Fosun International's Biogen position peaked at $711K in Q3 2018.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Fosun International's 13F filing for Q2 2019, filed 12 Aug 2019.